Clinical Trials in Atlanta

Showing 4061-4080 of 11,566 trials

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

NCT05848700

A Clinical Study to learn if SEP-363856 has physical dependence in adults with schizophrenia. This study will be held in approximately 6 study sites in the United States. It will be accepting male and female participants age 18 years to 65 years. Participation will be up to approximately10 weeks.

Schizophrenia

Otsuka Pharmaceutical Development & Commercialization, Inc.60 participantsStarted Jun 2023

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Miami Lakes, Florida, United States +4 more locations

COMPLETED< 1 mile

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

NCT05904210

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.

Hemophilia

Laboratoire français de Fractionnement et de Biotechnologies17 participantsStarted Nov 2023

Los Angeles, California, United States • Madera, California, United States • Atlanta, Georgia, United States +5 more locations

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Find Trials by Condition in Atlanta

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies